US equities |
NVDA $240.18 ▲+0.53% SPCX $172.13 ▲+0.61% MU $1,058.81 ▼-0.48% MRVL $286.64 ▲+5.67% AMD $654.01 ▲+3.52% INTC $114.29 ▼-1.64% AVGO $378.53 ▲+4.42% TSLA $379.45 ▲+0.19%
FinancialContent

DexCom, Inc. - Common Stock (NQ:DXCM)

83.51 -3.39 (-3.90%)
Delayed Quote Updated: 2:43 PM EDT, Oct 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
50 51 Next >
News headline image
Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin
From DexCom, Inc.
Via Business Wire
News headline image
DexCom vs. Insulet: Which Diabetes Stock Is a Better Buy in 2026? ↗
DexCom posts steady profits and global reach, while Insulet surges ahead with rapid revenue growth and a focused product line. Which strategy stands out? 
Via The Motley Fool
News headline image
Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026
From Dexcom
Via Business Wire
These S&P500 stocks have an unusual volume in today's session ↗
Via Chartmill
DexCom Inc (NASDAQ:DXCM): A GARP Stock with Affordable Growth and Strong Fundamentals ↗
Via Chartmill
DexCom (NASDAQ:DXCM) Beats Q1 Earnings Forecasts, But Guidance and Revenue Miss Fuel After-Hours Drop ↗
Via Chartmill
News headline image
2 Growth Stocks to Buy and Hold for a Decade ↗
They have outpaced the S&P 500 over the past 10 years. 
Via The Motley Fool
Topics Artificial Intelligence Stocks
News headline image
Dexcom Releases Customer Advisory Council Report, Outlining Ongoing Commitments to Enhancing Product Performance and User Experience
From Dexcom
Via Business Wire
News headline image
Dexcom Uncovers Theft of Scrapped Product, Notifies Potentially Impacted Users
From DexCom, Inc.
Via Business Wire
Stay informed with the top movers within the S&P500 index on Tuesday. ↗
Via Chartmill
News headline image
Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany
From DexCom, Inc.
Via Business Wire
News headline image
DexCom Maps G8 Launch, Coverage Expansion and Double-Digit Growth at Investor Day ↗
DexCom (NASDAQ:DXCM) used its 2026 Investor Day to outline a long-range plan centered on new product launches, broader insurance coverage for continuous glucose monitoring, international expansion and... 
Via MarketBeat
What's going on in today's session: S&P500 movers ↗
Via Chartmill
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
News headline image
Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day
From DexCom, Inc.
Via Business Wire
News headline image
Sell in May and Go Away—Starting With These 3 Stocks ↗
Oxford Club's Marc Lichtenfeld identifies three stocks worth selling in May—DexCom, Colgate-Palmolive, and Oracle—and breaks down the risks behind each call. 
Via MarketBeat
Topics Artificial Intelligence
News headline image
2 Mid-Cap Stocks with Impressive Fundamentals and 1 We Question
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. Howe... 
Via StockStory
News headline image
3 Quality Compounders Worth Your Attention
Quality compounders are flywheels. Said differently, they’re businesses that generate heaps of profits and consistently reinvest them to produce even more pr... 
Via StockStory
News headline image
5 Insightful Analyst Questions From DexCom’s Q1 Earnings Call
DexCom’s first quarter saw revenue growth driven by new product launches and increased adoption, particularly among people with type 2 diabetes who are not o... 
Via StockStory
Topics Earnings Economy
News headline image
3 Reasons Analysts Love DexCom ↗
Via MarketBeat
News headline image
Dexcom to Host Investor Day on May 14, 2026
From DexCom, Inc.
Via Business Wire
Friday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
What's going on in today's pre-market session: S&P500 movers ↗
Via Chartmill
News headline image
DXCM Q1 Deep Dive: U.S. Growth Moderates as Product Momentum and Coverage Expansion Drive Strategy
Medical device company DexCom (NASDAQ:DXCM) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 15% year on year to $1.19 bil... 
Via StockStory
News headline image
2 Nasdaq 100 Stocks with Solid Fundamentals and 1 We Find Risky
The Nasdaq 100 (^NDX) is known for housing some of the most innovative and fastest-growing companies in the market. But not every stock in the index is a win... 
Via StockStory
News headline image
DexCom (DXCM) Q1 2026 Earnings Transcript ↗
DexCom (DXCM) Q1 2026 Earnings Transcript 
Via The Motley Fool
Top S&P500 movers in Thursday's after hours session ↗
Via Chartmill
News headline image
DexCom (NASDAQ:DXCM) Exceeds Q1 CY2026 Expectations But Stock Drops
Medical device company DexCom (NASDAQ:DXCM) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 15% year on year to $1.19 b... 
Via StockStory
News headline image
Dexcom Reports First Quarter 2026 Financial Results
From DexCom, Inc.
Via Business Wire
News headline image
2026 Market Cap Madness Championship: Loren v. Emily ↗
It’s time to crown a winner: defending champion Emily Flippen faces off against Cinderella challenger Loren Horst in the Market Cap Madness World Championship. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
50 51 Next >